Show results for
Refine by
Cancer Centre Singapore Case Study Suppliers Serving Libya
53 companies found
based inMannheim, GERMANY
faCellitate is a venture that originated from BASF’s incubator, Chemovator, and it provides interactive consumables for advanced cell technologies and regenerative medicine in the 3D cell culture market. Its unique polymeric platform aims at ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inTewksbury, MASSACHUSETTS (USA)
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With over 400 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical ...
based inPleasanton, CALIFORNIA (USA)
29 years designing high affinity antibodies and immunoassays. Proudly serving the brightest minds in scientific research. Your experts in offering state-of-the-art ELISA kits, antibodies, custom reagents and analytical services in immunology, ...
based inLakewood, NEW JERSEY (USA)
We are an ISO9001 Certified manufacturer of enzymes and biochemicals for life science research, primary and stem cell isolation, bioprocessing, biopharma, diagnostics and biotechnology applications. Backed by over 75 years of expertise, we maintain ...
based inFujinomiya-shi, JAPAN
Tokai Hit is a global company that supports medical care and research around the world from the foot of Mt. Fuji. Tokai Hit consistently carries out the development, manufacturing, and sales of the 'Incubation system for microscope', which is an ...
based inHayward, CALIFORNIA (USA)
Biolog, Inc. is a privately held company that began operations in Northern California in 1984. The company’s product lines have been built upon patented technology that greatly simplifies testing of cells. Biolog’s first products were introduced in ...
based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform technologies such as small molecule innovative anticancer drug ...
based inNashville, TENNESSEE (USA)
Aspect Imaging Ltd is a global leader in the design and development of compact MR imaging solutions for preclinical and medical applications. The company’s breakthrough technology and related IP –compact high-performance permanent magnets –is the ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their ...
based inSan Diego, CALIFORNIA (USA)
Epitope Diagnostics Inc., is a certified medical device manufacture company that focuses on niche immunoassays for the global diagnostics and research industries. We specialize in ELISA kits, rapid tests, and antibodies. Epitope Diagnostics Inc. ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Dubermatinib (TP-0903) is an investigational inhibitor of AXL receptor tyrosine kinase (RTK), a protein known to be involved in acquiring resistance to chemotherapeutics, immune evasion, and developing metastatic capacity in cancer ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
Indication: Ovarian Cancer. Research: iNK cells [TAG-72 CAR + gene ...
based inHeidelberg, GERMANY
Since 25 years we develop, produce and sell our innovative products for various fields of medical and laser technology. In 2020 we celebrate our 25th anniversary. MRC Systems GmbH was established in 1995 as a spin-off of the University of Heidelberg ...
based inVillejuif, FRANCE
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...
based inKirkland, Montréal, QUEBEC (CANADA)
Jubilant Radiopharma is a global leader in the development, manufacturing, and commercialization of radiopharmaceuticals used for the diagnosis and treatment of disease. We serve our customers – and through them patients – with high-quality and ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inMenomonee Falls, WISCONSIN (USA)
Enthermics Medical Systems began in 1980 as a pioneer in the whole body hyperthermia research field with a revolutionary device utilizing a unique, patented warming technology. Used primarily in advanced cancer research, this device eventually led ...
based inSugar Land, TEXAS (USA)
TransLite LLC is a small high tech company comprising dedicated people who design, manufacture and sell medical devices that can help reduce the pain and trauma to patients during venous access and treatment of varicose veins. Over 70,000 medical ...
based inChatswood, AUSTRALIA
Next Science® pioneers innovative, proprietary technologies to address one of the leading causes of antimicrobial resistance, bacterial biofilms. With proven, experienced management and scientific leadership, Next Science and its partners deliver ...
